Paragon 28 Delivers Strong Performance Despite Supply Pinch
The company grew in the mid-teens during the third quarter of 2022, driven by sales force and active surgeon base...
The company grew in the mid-teens during the third quarter of 2022, driven by sales force and active surgeon base...
The company grew more than 23% in 3Q23 but ultimately reduced its guidance because of higher-than-expected seasonality during the summer....
The company grew in the low single digits in the third quarter of 2023 as its OA pain sales volume...
The company's orthopedic sales grew in the mid-teens during the third quarter of 2023, as it continues to win market...
The company grew in the mid-single-digits in the third quarter of 2023, driven by knee replacement and its SET product...
The company grew more than 50% in the third quarter of 2023 as it benefit from continued share growth and...
The company grew more than 40% in the third quarter of 2023 as it procedural solutions continue winning significant market...
The company grew nearly 29% in the third quarter of 2023, notching its sixth consecutive quarter of record revenues....
The company grew in the high-single-digits in the third quarter of 2023, driven by market recovery and improving operational performance....
The company grew in the mid-single-digits for the third quarter of 2023, driven by new products and better-than-expected orthobiologics sales....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.